Farnsworth, Dylan A.
Inoue, Yusuke
Johnson, Fraser D.
de Rappard-Yuswack, Georgia
Lu, Daniel
Shi, Rocky
Ma, Lok In Josephine http://orcid.org/0000-0002-9457-7008
Mattar, Marissa S.
Somwar, Romel
Ladanyi, Marc
Unni, Arun M. http://orcid.org/0000-0003-0530-1470
Lockwood, William W. http://orcid.org/0000-0001-9831-3408
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-148725)
Memorial Sloan-Kettering Cancer Center (P30 CA008748)
Article History
Received: 4 May 2022
Accepted: 1 November 2022
First Online: 23 November 2022
Competing interests
: A.M.U. and W.W.L. are scientific advisors for Hyperbio Therapeutics. Marc Ladanyi has received advisory board compensation from Merck, Bristol-Myers Squibb, Takeda, Bayer, Lilly Oncology, Janssen, and Paige.AI. Research grants unrelated to the current study was obtained from Hesinn Heathcare, Merus, LOXO Oncology and Elevation Oncology Inc. Romel Somwar has received research grants, unrelated to the current study, from Merus, LOXO Oncology and Elevation Oncology Inc. and Helsinn.